Rana Lab

Rana Preeclampsia Lab Publications & Media

Rana S, Stanhope RC, Gaffey T, Morrey BF, Dumesic DA.  Retroperitoneal endometriosis causing unilateral hip pain.  Obstet Gynecol 2001; 98:970-2. PMID: 11704226.

Kumar RM, Uduman S, Rana S, Kochiyil JK, Usmani A, Thomas L.  Sera-prevalence and mother-to infant transmission of Hepatitis E virus among pregnant women in the United Arab Emirates.  Euro J Obstet Gynecol Reprod Biology 2001; 100: 9-15. PMID: 11728649.

Rana S, Warren BK, Yamada SD.  Stage IIIC small cell carcinoma of the ovary:  survival with conservative surgery and chemotherapy.  Obstet Gynecol 2004; 103(5 Pt2): 1120-3. PMID: 15121630.

Abramowicz JS, Rana S, Abramowicz S. Fetal cheek-to-cheek diameter in the prediction of mode of delivery.  Am J Obstet Gynecol 2005; 192 (4): 1205-13. PMID: 15846203.

Rana S, Lindheimer M, Hibbard J, Pliskin N. Neuropsychological performance in normal pregnancy and preeclampsia. Am J Obstet Gynecol 2006; 195 (1): 186-91. PMID: 16579917.

Cohen A, Lim KH, Lee Y, Rana S, Karumanchi SA, Brown F.  Circulating levels of antiangiogenic marker soluble FMS-like tyrosine kinase1 are elevated in women with pregestational diabetes and preeclampsia:  angiogenic markers in preeclampsia and preexisting diabetes.  Diabetes Care 2007; 30(2): 375-7. PMID: 17259514.

Rana S, Venkatesha S, DePaepe M, Chien E, Paglia M, Karumanchi SA.  Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors.  Obstet Gynecol 2007; 109(2Pt2): 549-52. PMID: 17267891.

Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, Tamez H, Thadhani R.  Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.  Hypertension 2007; 50 (1): 137-42. PMID: 17515455.

Signore C, Mills JL, Qian C, Yu KF, Rana S, Karumanchi SA, Levine RJ.  Circulating soluble endoglin and placental abruption.  Prenat Diagn. 2008; 28(9): 852-8. PMID: 18702104.

Shan HY, Rana S, Epstein FH, Stillman IE, Karumanchi SA, Williams ME.  Use of circulating antiangiogenic factors to differentiate other hypertensive disorders from preeclampsia in a pregnant woman on dialysis.  Am J Kidney Dis. 2008; 51(6): 1029-32. PMID: 18455853.

Rauh-Hain A, Rana S, Tamez H, Wang A, Cohen B, Cohen A, Brown F,  Ecker JL, Karumanchi SA, Thadhani R: Risk for developing gestational diabetes in women with twin pregnancies. J Matern Fetal Neonatal Med. 2009; 25:1-7. PMID: 19340713.

Young B, Levine RJ, Salahuddin S, Qian C, Lim KH, Karumanchi SA, Rana S: The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome. J Matern Fetal Neonatal Med. 2010; 23(5): 366-70. PMID: 19701867.

Young B, Takoudes T, Lim KH, Rana S: Rupture of the posterior cul-de-sac during spontaneous labor. Obstet Gynecol. 2010; 115: 414-7. PMID: 20093863.

Steinberg G, Lee C, Rauh-Hain JA, Ecker J, Khankin EV, Hsu CD, Cohen B, Rana S, Karumanchi SA, Thadhani R, Hacker MR, Lim KH. Early-pregnancy soluble Fas levels in idiopathic small-for-gestational-age pregnancies. Am J Obstet Gynecol. 2010; 202(3): 299. e1-7. PMID: 20207247.

Powe CE, Seely EW, Rana S, Bhan I, Ecker J, Karumanchi SA, Thadhani R. First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia. Hypertension. 2010; 56(4): 758-63. PMID: 20733087.

Mijal RS, Holzman CB, Rana S, Karumanchi SA, Wang J, Sikorskii A. Mid-pregnancy levels of angiogenic markers in relation to maternal characteristics. Am J Obstet Gynecol. 2011; 204(3): 244.e1-12. PMID: 21145529.

Powe CE, Ecker J, Rana S, Wang A, Ankers L, Ye J, Levine RJ, Karumanchi SA, Thadhani R. Preeclampsia and the risk of large for gestational age infants. Am J Obstet Gynecol. 2011; 204(5): 425.e1-6. PMID: 21371687.

Silasi M, Rana S, Powe CE, Cohen B, Lim KH, Karumanchi SA, Stillman I. Trisomy 13 and placental angiogenic proteins. Am J Obstet Gynecol. 2011; 204(6): 546.e1-4. PMID: 21507376.

Rhee J, Young BC, Rana S. Angiogenic Factors and Renal disease in Pregnancy. Case reports in Obstetrics and Gynecology. 2011. PMID: 22567501.

Poston L, Igosheva N, Mistry HD, Seed PT, Shennan AH, Rana S, Karumanchi SA, Chappell LC. The role of oxidative stress and antioxidant supplementation in pregnancy disorders. Am J Clin Nutr. 2011; 94(6): 1980S-5S. PMID: 21613560.

Mijal RS, Holzman CB, Rana S, Karumanchi A, Wang J, Sikorskii A. Midpregnancy levels of angiogenic factors and pathways to preterm delivery. J Matern Fetal Neonatal Med. 2012; 25(7): 1135-41. PMID: 21939291.

Vadnais, M, Rana S, Quant H, Salahuddin S, Dodge L, Lim KH, Karumanchi SA, Hacker M. The impact of magnesium sulfate therapy on angiogenic factors in preeclampsia. Pregnancy Hypertens. 2012; 2(1): 16-21. PMID: 22247820.

Young B, Hacker M, Rana S. Physician’s knowledge of future vascular disease in women with preeclampsia. Hypertens Pregnancy. 2012; 31(1): 50-8. PMID: 21332326.

Rajakumar A, Cerdeira AS, Rana S, Zsengeller A, Edmunds L, Jeyabalan A, Hubel CA, Stilmann IE, Parikh SM, Karumanchi SA. Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating sFlt1 in preeclampsia. Hypertension. 2012; 59(2): 256-64. PMID: 22215706.

Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, Lim KH, Wenger JB, Thadhani R, Karumanchi SA. Angiogenic Factors and the Risk of Adverse Outcomes in Women with Suspected Preeclampsia. Circulation. 2012; 125(7): 911-9. PMID: 22261192.

Schnettler WT, Hacker MR, Barber R, Rana S. Management of abnormal serum markers in the absence of aneuploidy or neural tube defects. J Matern Fetal Neonatal Med. 2012; 25(10): 1895-8. PMID: 22372385.

Bixel K, Silasi M, Zelop CM, Lim KH, Zsengeller Z, Stillman I, Rana S. Placental Origins of Angiogenic Dysfunction in Mirror Syndrome. Hypertens Pregnancy. 2012; 31(2): 211-7. PMID: 22150085.

Quant H, Arden D, Takoudes T, Rana S. Angiogenic factors and pregnant woman with new onset seizures. Hypertens Pregnancy. Hypertens Pregnancy. 2012; 31(2): 207-10. PMID: 22380455.

Khankin EV, Hacker MR, Zelop CM, Karumanchi SA, Rana S. Intravital high frequency ultrasonography of cardiovascular and uteroplacental blood flow in mouse pregnancy. Pregnancy Hypertens. 2012; 2(2): 84-92. PMID: 22544045.

Patten IS, Rana S#, Shahul S, Rowe GC, Jang C, Liu L, Hacker MR, Rhee JS, Mitchell J, Mahmood F, Hess P, Farrell C, Koulisis N, Khankin EV, Burke SD, Tudorache I, Bauersachs J, Monte F, Hilfiker-Kleiner D, Karumanchi SA, Arany Z. Cardiac Angiogenic Imbalance Leads to Peri-partum Cardiomyopathy. Nature. 2012. 2012; 485: 333–338.  #equal contribution. PMID: 22596155.

Rana S, Hacker MR, Merport Modest A, Salahuddin S, Lim KH, Verlohren S, Perschel FH, Karumanchi SA. Circulating Angiogenic Factors and Risk of Adverse Maternal and Perinatal Outcomes in Twin Pregnancies with Suspected Preeclampsia. Hypertension. 2012; 60(2): 451-8. PMID: 22753210.

Shahul S, Rhee J, Hacker MR, Gulati G, Mitchell JD, Hess P, Mahmood F, Arany Z, Rana S, Talmor D. Subclinical Left Ventricular Dysfunction in Preeclamptic Women with Preserved Left Ventricular Ejection Fraction: A 2D Speckle Tracking Imaging Study. Circ Cardiovasc Imaging. 2012; 5(6): 734-9. PMID: 22891044.

Rana S, Cerdeira AS, Wenger J, Salahuddin S, Lim KH, Ralston RJ, Thadhani R, Karumanchi SA. Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia. PLoS One. 2012; 7(10): e48259. PMID: 23110221.

Lely TA, Salahuddin S, Holwerda KM, Karumanchi SA, Rana S. Circulating Lymphangiogenic Factors in Preeclampsia. Hypertens Pregnancy. 2013; 32(1): 42-9. PMID: 22957504

Schaarschmidt W, Rana S, Stepan H. The course of angiogenic factors in early- versus late-onset preeclampsia and HELLP syndrome. J Perinat Med. 2013; 41(5): 5111-6. PMID: 23612628.

Schnettler WT, Dukhovny D, Wenger J, Salahuddin S, Ralston SJ, Rana S. Cost and resource implications with serum angiogenic factor estimation in the triage of preeclampsia. BJOG. 2013; 120(10): 1224-32. PMID: 23647884.

Rana S, Schnettler WT, Powe C, Wenger J, Salahuddin S, Cerdeira AS, Verlohren S, Perschel FH, Arany Z, Lim KH, Thadhani R, Karumanchi SA. Clinical Characterization and Outcomes of Preeclampsia with Normal Angiogenic Profile. Hypertens Pregnancy. 2013; 32(2): 189-201. PMID: 23725084.

Rana S, Karumanchi S.A, Lindheimer MD. Angiogenic Factors in Diagnosis, Management, and Research in Preeclampsia. Hypertension. 2014; 63(2): 198-202. PMID: 24166749.

Bdolah Y, Elchalal U, Natanson-Yaron S, Yechiam H, Bdolah-Abram T, Greenfield C, Goldman-Wohl D, Milwidsky A, Rana S, Karumanchi SA, Yagel S, Hochner-Celnikier D. Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1. Hypertens Pregnancy. 2014; 33(2): 250-9. PMID: 24304210.

Cohen AL, Wenger JB, James-Todd T, Lamparello BM, Halprin E, Serdy S, Fan S, Horowitz GL, Lim KH, Rana S, Takoudes TC, Wyckoff JA, Thadhani R, Karumanchi SA, Brown FM. The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes. Hypertens Pregnancy. 2014; 33(1): 81-92. PMID: 24354578.

Rana S, Rajakumar A, **Geahchan C, Salahuddin S, **Cerdeira AS, Burke S, George E, Granger J, Karumanchi SA. Ouabain Downregulates sFlt1 Production by Inhibiting HSP27-Dependent HIF-1a Protein Expression. FASEB J. 2014; 28(10): 4324-34. PMID: 24970393.

Baltiajan K, Hecht J, Wenger J, Salahuddin S, Zsengeller Z, Thadhani R, Karumanchi SA, Rana S. Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia. Hypertens Pregnancy. 2014;33(4):427-39. PMID: 25062083.

March MI, Gupta M, Perport Modest A, Wu L, Hacker MR, Martin C, Rana S. Maternal Risk Factors for Neonatal Necrotizing Enterocolitis.  J Matern Fetal Neonatal Med. 2014; 27:1-6. PMID: 25162307.

Raghuraman N, March MI, Hacker MR, Merport Modest A, Wenger J, Narcisse R, Louis J, Scott J, Rana S. Adverse Maternal and Fetal Outcomes and Deaths related to Preeclampsia and Eclampsia in Haiti. Pregnancy Hypertens, 2014; 4(4):279–286. PMID: 26104817.

Palomaki GE, Haddow JE, Haddow H, Salahuddin S, Geahchan C, Cerdeira AS, Verlohren S, Perschel FH, Horowitz G, Thadhani R, Karumanchi SA, Rana S. Modeling Risk for Angiogenesis-Related Maternal Syndrome Requiring Early Delivery in a Cohort of Women Referred for Preeclampsia Evaluation. Prenat Diagn. 2015; 35(4): 386-93. PMID: 25641027.

March MI, Geahchan C, Wenger J, Raghuraman N, Berg A, Haddow H, Mckeon BA, Narcisse R, David JL, Scott J, Thadhani R, Karumanchi SA, Rana S. Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia. PLoS One. 2015 May 12; 10(5): e0126815. PMID: 25965397.

Goel A, Maski MR, Bajracharya S, Wenger JB, Zhang D, Salahuddin S, Shahul S, Thadhani R, Seely EW, Karumanchi SA, Rana S. Epidemiology and Mechanisms of De Novo Hypertension in the Postpartum Period. 2015. Circulation. 2015 Nov 3; 132 (18): 1726-33. PMID: 26416810.

Shahul S, Mahmood E, Minhaj MM, Robb D. Kociol RD, Nizamuddin J, Wenger JB, Mueller A, Shaefi S, Scavone B, Tung A, Talmor D, Rana S. Racial Disparities in Maternal and Fetal Outcomes in Women with Preeclampsia/Eclampsia. Hypertens Pregnancy. 2015; 34(4):506-15. PMID: 26636247.

Kim MY, Buyon JP, Guerra MM, Rana S, Laskin CA, Petri M, Lockshin MD, Sammaritano L, Branch WD, Porter FT, Merrill JT, Stephenson MD, Gao Q, Karumanchi SA, and Salmon JE. Angiogenic Factor Imbalance Early in Pregnancy Predicts Adverse Outcomes in Patients with Lupus and Antiphospholipid Antibodies: Results of the PROMISSE Study. Am J Obstet Gynecol. 2016; 214(1): 108.e1-108.e14. PMID: 26432463.

Baltajian K, Bajracharya S, Wenger JB, Berg A, Geahchan C, Salahuddin S, Thadhani R, Karumanchi SA, Rana S. Sequential angiogenic factor estimation to predict adverse pregnancy outcomes among patients admitted for evaluation of preeclampsia. Am J Obstet Gynecol. 2016 Jul; 215(1):89. e1-89. e10. PMID: 26827880.

Damp J, Givertz MM, Semigran M, Alharethi R, Ewald G, Felker GM, Bozkurt B, Boehmer J, Haythe J, Skopicki H, Hanley-Yanez K, Pisarcik J, Halder I, Gorcsan J 3rd, Rana S, Arany Z, Fett JD, McNamara DM; IPAC Investigators. Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study. JACC Heart Fail. 2016 May; 4(5):380-8. PMID: 26970832.

Salahuddin S, Wenger JB, Zhang D, Thadhani R, Karumanchi SA, Rana S. KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes. Hypertens Pregnancy. 2016;35(3): 330-45. PMID: 27028795.

Shahul S, Medvedofsky D, Wenger JB, Nizamuddin J, Brown SM, Bajracharya S, Salahuddin S, Thadhani R, Mueller A, Tung A, Lang RM, Arany Z, Talmor D, Karumanchi SA, Rana S. Circulating Antiangiogenic Factors and Myocardial Dysfunction in Hypertensive Disorders of Pregnancy. Hypertension. 2016 Jun; 67(6): 1273-80. PMID: 27113052.

Zsengellér ZK, Rajakumar A, Hunter JT, Salahuddin S, Rana S, Stillman IE, Ananth Karumanchi S. Trophoblast mitochondrial function is impaired in preeclampsia and correlates negatively with the expression of soluble fms-like tyrosine kinase 1. Pregnancy Hypertens. 2016; 6 (4):313-319. PMID: 27939475.

Nadkarni NA, Rajakumar A, Mokhashi N, Burke SD, Rana S, Salahuddin S, Dang Q, Thadhani R, Krishnan R, Stossel TP, Karumanchi SA. Gelsolin is an endogenous inhibitor of syncytiotrophoblast extracellular vesicle shedding in pregnancy. Pregnancy Hypertens. 2016; 6 (4):333-339. PMID: 27939478.

Banayan J, Rana S, Mueller A, Tung A, Ramadan H, Arany Z, Nizamuddin J, Novack V, Scavone B, Brown SM, Shahul S. Cardiogenic shock in pregnancy: Analysis from the National Inpatient Sample. Hypertens Pregnancy. 2016 Nov 11:1-7. PMID: 27835031.

Siddiqui M, Minhaj M, Mueller A, Tung A, Scavone B, Rana S, Shahul S. Increased Perinatal Morbidity and Mortality Among Asian American and Pacific Islander Women in the United States. Anesth Analg. 2017 Mar;124(3):879-886. PMID: 28099290.

Ramadan H, Rana S, Mueller A, Medvedofsky D, Nizamuddin J, Bajracharya S, Salahuddin S, Thadhani R, Tung A, Arany Z, Karumanchi SA, Shahul S. Myocardial performance index in hypertensive disorders of pregnancy: The relationship between blood pressures and angiogenic factors. 2017. Hypertens Pregnancy. PMID: 28609171.

Dutta A, Brito K, Khramstova G, Mueller A, Chinthala S, Alexander D, Adu D, Ibigbami T, Olamijulo J, Odetunde A, Adigun K, Pruitt L, Olopade O, Ojengbede O, Rana S, Olopade CO. Household air pollution and angiogenic factors in pregnant Nigerian women: A randomized controlled ethanol cookstove intervention. 2017. Science of the Total Environment 599–600 (2017) 2175–2181. PMID: 28575932.

Chhabra N, Gupta A, Chibber R, Minhaj M, Hofer J, Mueller A, Tung A, O’Connor MF, Scavone B, Rana S, Shahul SS. Outcomes and mortality in parturient and non-parturient patients with peripartum cardiomyopathy: a national readmission database study. Pregnancy Hypertens. 2017 Oct; 10 :143-148. PMID: 29153668.

Kang E, Sugarman R, Ramadan H, Mueller A, Shahul S, Perdigao JL, Louis DJ, Narcisse R, Sannon H, Magee L, Rana S. Prevalence of postpartum hypertension in rural Haiti. Pregnancy Hypertens. 2017 Oct; 10 :135-142. PMID: 29153666.

Shahul S, Ramadan H, Mueller A, Nizammudin J, Nasim R, Perdigao JL, Chinthala S, Tung A, Rana S. Abnormal mid-trimester cardiac strain in women with chronic hypertension predates superimposed preeclampsia. Pregnancy Hypertens. 2017 Oct ; 10:251-25. PMID: 29111424

Dutta A, Khramstova G, Brito K, Alexander D, Mueller A, Chinthala S, Adu D, Ibigbami T, Olamijulo J, Odetunde A, Adigun K, Pruitt L, Hurley I, Olopade O, Ojengbede O, Rana S, Olopade CO. Household Air Pollution and Chronic Hypoxia in the Placenta of Pregnant Nigerian Women: A Randomized Controlled Ethanol Cookstove Intervention. Sci Total Environ. 2018 Apr 1;619-620:212-220. PMID: 29149745.

Chan SL, Rana S, Chinthala S, Salahuddin S, Yeo KT. Analytical validation of soluble fms-like tyrosine and placental growth factor assays on BRAHMS KRYPTOR Compact Plus automated immunoassay platform. Pregnancy Hypertens. 2018 Jan; 11:66-70. PMID: 29523276.

Shahul S, Ramadan H, Nizamuddin J, Mueller A, Patel V, Dreixler J, Tung A, Lang RM, Weinert L, Nasim R, Chinthala S, Rana S. Activin A and Late Postpartum Cardiac Dysfunction Among Women With Hypertensive Disorders of Pregnancy. Hypertension. 2018 Jul;72(1):188-193. PMID: 29844146. Editor’s Choice, 2019.

Rana S, Salahuddin S, Mueller A, Berg AH, Thadhani RI, Karumanchi SA. Angiogenic Angiogenic Biomarkers in Triage and Risk for Preeclampsia with Severe Features. Pregnancy Hypertens. 2018 Jul; 13:100-106. PMID: 30177034.

Minhas R, Young D, Naseem R, Mueller A, Chinthala S, Perdigao JP, Yeo KT, Chan SL, Tung A, Bregand White J, Shahul S, Rana S. Association of levels of blood pressure control during pregnancy and angiogenic profile at delivery among women with chronic hypertension. Pregnancy Hypertens. 2018 Oct; 14: 110-114. PMID: 30527096.

Nizamuddin J, Gupta A, Patel V, Minhaj M, Nizamuddin SL, Mueller AL, Naseem H, Tung A, Rana S, Shahul S. Hypertensive Diseases of Pregnancy Increase Risk of Readmission With Heart Failure: A National Readmissions Database Study. Mayo Clin Proc. 2019 May;94 (5):811-819. PMID: 30577972.

Lopes Perdigao JL, Chinthala S, Mueller A, Minhas R, Ramadan H, Nasim R, Naseem H, Young D, Shahul S, Chan SL, Yeo KJ, Rana S. Angiogenic factors and adverse maternal outcomes among admitted patients with hypertensive disorders of pregnancy. Hypertension. 2019 Apr; 73(4):868-877. PMID: 30798660. Selected as high impact paper in HTN- summer 2019.

Wang V, Mueller A, Minhas R, Yan J, Guo J, Rana S. Understanding and Comparing Practices of Managing Patients with Hypertensive Disorders of Pregnancy in Urban China and the United States. Pregnancy Hypertens. 2019 Jul 23; 17:253-260. PMID: 31487649.

Harrison JN, Arnolds DE, Banayan JM, Rana S, Schnettler WT, Neuburger PJ. Surgical Excision of a Left Atrial Myxoma During the Second Trimester of Pregnancy. J Cardiothorac Vasc Anesth. 2020 Feb;34(2):530-536. PMID: 31818529.

Proussaloglou E, Mueller A, Minhas R, Rana S. Severe Antepartum Hypertension and Associated Peripartum Morbidity among Pregnant Women in an Urban Tertiary Care Medical Center. Pregnancy Hypertens. 2020 Jan; 19:31-36. PMID: 31877438.

Heimberger S, Perdigao JL, Mueller A, Shahul S, Naseem H, Minhas R, Chintala S, Rana S. Effect of Blood Pressure Control in Early Pregnancy and Clinical Outcomes in African American Women with Chronic Hypertension. Pregnancy Hypertens. 2020 Apr; 20:102-107. PMID: 32229425.

Heimberger S, Mueller A, Ratnaparkhi R, Perdigao JL, Rana S. Angiogenic factor abnormalities and risk of peripartum complications and prematurity among urban predominantly obese parturients with chronic hypertension. Pregnancy Hypertens. 2020 Apr; 20:124-130. PMID: 32299059.

Naseem H, Dreixler J, Mueller A, Tung A, Dhir R, Chibber R, Granger, Bakrania B, DeMartelly V, Rana S, Shahul S. The Association Between Antepartum Aspirin Administration, Activin A and Cardiac Function During Pregnancy. J Am Heart Assoc. 2020 Jun 16;9(12):e015997. PMID: 32495688.

Suresh S, Mueller AM, Salahuddin S, Naseem H, Dhir R, Rana S. Evaluation of Angiogenic Factors in the Decision to Admit Women With Suspected Preeclampsia. Pregnancy Hypertens. 2020; 21:124-131. PMID: 32505096.

Marinić M, Rana S, Lync VJ. Derivation of endometrial gland organoids from term placenta. Placenta. 2020; 101: 75-79. PMID: 32937244.

Yang W, Li Q, Duncan JW, Bakrania BA, Bradshaw JL, Granger JP, Rana S, Spradley FT. Luteolin-induced vasorelaxation in uterine arteries from normal pregnant rats. Pregnancy Hypertens. 2020 Oct 23;23:11-17. PMID: 33161224.

Sakabe NJ, Aneas I, Knoblauch N, Sobreira DR, Clark N, Paz C, Horth C, Ziffra R, Kaur H, Liu X, Anderson R, Morrison J, Cheung VC, Grotegut C, Reddy TE, Jacobsson B, Hallman M, Teramo K, Murtha A, Kessler J, Grobman W, Zhang G, Muglia LJ, Rana S, Lynch VJ, Crawford GE, Ober C, He X, Nóbrega MA. Transcriptome and regulatory maps of decidua-derived stromal cells inform gene discovery in preterm birth. Sci Adv. 2020 Dec 2;6(49):eabc8696. PMID: 33268355.

Soundararajan R, Suresh S, Mueller A, Heimberger S, Sathyanarayana C, Mahesh S, Madhuprakash S, Rana S. Real Life Outpatient Biomarker Use in Management of Hypertensive Pregnancies in third trimester in a Low Resource SeTting: ROBUST Study. Pregnancy Hypertens. 2020 Dec 3;23:97-103. PMID: 33307400.

DeMartelly VA, Dreixler J, Tung A, Mueller AM, Heimberger S, Fazal A, Naseem H, Lang R, Kruse E, Yamat M, Granger JP, Bhavisha B, Rodriquez-Kovacs J, Rana S, Shahul S. Postpartum cardiac dysfunction among women with preeclampsia paper. J Am Heart Assoc. 2021 Feb;10(5):e018526. PMID: 33619970.

Goli R, Li J, Brandimarto J, Levine LD, Riis V, McAfee Q, DePalma S, Haghighi A, Seidman JG, Seidman CE, Jacoby D, Macones G, Judge DP, Rana S, Margulies KB, Cappola TP, Alharethi R, Damp J, Hsich E, Elkayam U, Sheppard R, Alexis JD, Boehmer J, Kamiya C, Gustafsson F, Damm P, Ersbøll AS, Goland S, Hilfiker-Kleiner D, McNamara DM, Arany Z; IMAC-2 and IPAC investigators. Genetic and phenotypic landscape of peripartum cardiomyopathy. Circulation. 2021 Apr 20. PMID: 33874732.

Arenas GA, Tang NY, Mueller A, Perdigao JL, Kaur H, Abramowicz JS, Mussatt K, Yeo KJ, Rana S. Use of the angiogenic biomarker profile to risk stratify patients with fetal growth restriction. Am J Obstet Gynecol MFM. 2021. PMID: 33991706.

Njoroge S, Kuriloff M, Mueller A, Lopes Perdigao J, Dhir R, Rana S. The interval between births and the risk of recurrent preeclampsia among predominantly high-risk women in urban tertiary care center. Pregnancy Hypertens. 2021 May 14;25:7-11. PMID: 34020331.

Johnson KM, Smith L, Modest AM, Salahuddin S, Ananth Karumanchi S, Rana S, Young BC. Angiogenic factors and prediction for ischemic placental disease in future pregnancies. Pregnancy Hypertens. 2021 May 14;25:12-17. PMID: 34020330.

Suresh S, Duncan C, Kaur H, Mueller AM, Tung A, Perdigao JL, Khosla K, Dhir R, Stewart K, Wallace K, Ahn R, Rana S. Postpartum Outcomes with Systematic Treatment And Management of Postpartum Hypertension (STAMPP HTN). Obstet Gynecol. 2021 Nov 1;138(5):777-787. PMID: 34619718.

Khosla K, Espinoza J, Perlaza L, Gencay M, Mueller AL, Harris JM, Wolf C, Posnett JW, Woelkers DA, Rana S. Cost effectiveness of the sFlt1/PlGF ratio test as an adjunct to the current practice of evaluating suspected preeclampsia in the United States. Pregnancy Hypertens. 2021 Oct 29; 26:121-126. PMID: 34749060.

Verlohren S, Brennecke SP, Galindo A, Karumanchi SA, Mirkovic LB, Schlembach D, Stepan H, Vatish M, Zeisler H, Rana S. Clinical interpretation and implementation of the sFlt-1/PGIF ratio in the prediction, diagnosis and management of preeclampsia and related disorders. Pregnancy Hypertens. 2021 Dec 8. PMID: 34915395  

 

Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Singer J, Gafni A, Gruslin A, Helewa M, Hutton E, Lee SK, Lee T, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015; 372(24):2367-8. Site PI for CHIPS group. PMID: 26061848.

Magee LA, for the CHIPS Study Group, Dadelszen PV, Singer, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni IA, Gruslin A, Helewa M, Hutton E, Koren G, SK Lee SK, AG Logan AG, Ganzevoort JW, Welch R, Thornton JG, Moutquins J-M. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial. BJOG.2016;123(7):1143-51. Site PI for CHIPS group. PMID: 26265372.

Magee LA; CHIPS Study Group, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Gruslin A, Helewa M, Hutton E, Koren G, Lee SK, Logan AG, Ganzevoort JW, Welch R, Thornton JG, Moutquin JM. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa? BJOG. 2016; 123(7):1135-41. Site PI for CHIPS group. PMID: 26259808.

Pels A, Mol BWJ, Singer J, Lee T, von Dadelszen P, Ganzevoort W, Asztalos E, Magee LA; CHIPS Study Group. Influence of Gestational Age at Initiation of Antihypertensive Therapy: Secondary Analysis of CHIPS Trial Data (Control of Hypertension in Pregnancy Study). Hypertension. 2018 Jun;71(6):1170-1177. PMID: 29686009

Hakim S, Bano I, Bhardwaj NA, Anis A, Rana S. Dermoid cyst of mons pubis: a case report. J Obstet Gynecol India 2000; 51: 121.

Saxena K, Haroon S, Rabbani T, Rana S.  Blood flow studies in evaluation of fetal wellbeing: A study of normal and abnormal pregnancies.  J Obstet Gynecol lndia 2001; 51:64-72.

Rana S.  Practical strategies in Obstetrics & Gynecology (book review). Fertility Sterility 2000,74 (2): 425.

Rana S, Lindheimer MD, Karumanchi SA.  Angiogenic proteins as markers for predicting preeclampisa.  Expert Review of Obstet Gynecol 2007; 2(1): 61-65.

Wang A, Rana S, Karumanchi SA: Preeclampsia. Physiology. 2009; 24:147-58.

Tjoa M, Khankin E, Rana S, Karumanchi SA. Book Chapter: Angiogenic and anti-angiogenic factors. Placental Bed Disorders: Basic Science & its translation to obstetrics, Cambridge University Press. 2010, Section 7, Chapter 21.

Maski M, Rana S, Karumanchi SA. Book Chapter: Biomarkers in Obstetric Medicine. Biomarkers in Medicine, Drug Discovery, and Environmental Health, John Wiley and Sons. 2010, Section II, Chapter 13.

Silasi M, Cohen B, Karumanchi SA, Rana, S: Abnormal Placentation, Angiogenic Factors, and the Pathogenesis of Preeclampsia. Obstetrics and Gynecology Clinics of North America. 2010; 37(2): 239-253.

Rana S, Karumanchi SA, Norwitz E. Book Chapter: Screening for hypertensive disorders of pregnancy. Hypertension in Pregnancy, Cambridge University Press. 2010, Chapter 4.

Goel A and Rana S. Angiogenic Factors in Preeclampsia: Potential for Diagnosis and Treatment. Curr Opin Nephrol Hypertens. 2013; 22(6): 643-650.

Karumanchi SA, Rana S, Robert Taylor. Book Chapter: Angiogenesis and Preeclampsia. Chesley’s hypertensive disorders in pregnancy, Fourth Edition. Elsevier Inc. 2014, Chapter 6.

Rana S, Karumanchi SA. Book Chapter: Pathophysiology of preeclampsia. Fetal and Neonatal Physiology, Fifth edition. Elsevier Inc, 2015, Chapter 172.

Rana S, Karumanchi SA. Book Chapter: Angiogenic factors in Pre-eclampsia. World Clinics Obstetrics and Gynecology- Preeclampsia. 2016; 5(1): pp1-143.

Rana S, Sannon H. Angiogenic proteins: Can these biomarkers help to prevent maternal deaths related to preeclampsia? Editorial. Hypertension. 2017 Mar; 69(3):401-403.

Rana S. Does vasoactive peptide ELABELA reveal essential mechanisms for preeclampsia development?”. OB GYN management. October 29, 2017.

Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: Pathophysiology, Challenges, and Perspectives. Review. Circ Res. 2019 Mar 29;124(7):1094-1112. PMID: 30920918.

Rana S. Does planned early delivery makes sense in women with preterm preeclampsia”. OB GYN management. December, 2019.

Rana S, Karumanchi SA. Book Chapter: Pathophysiology of preeclampsia. Fetal and Neonatal Physiology, Fifth edition. Elsevier Inc, 2020, Chapter 172.

Rana S, Burke SD, Karumanchi SA. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. AJOG, 2020. PMID: 33096092.

Sunitha Suresh, Rana S. The real world use of biomarkers in management of hypertension during pregnancy- adjunct to clinical care. Editorial, Hypertension. 2021 Feb;77(2):472-474. PMID: 33439732.

Docheva, N, Rana S. Editorial. Treat it while you can: Use of Lasix in Management of Postpartum Hypertension. Editorial, Hypertension. 2021 May 5;77(5):1525-1527.PMID PMID: 33826400.

Khosla K, Heimberger S, Nieman KM, Tung A, Shahul S, Staff AC, Rana S. Long-Term Cardiovascular Disease Risk in Women After Hypertensive Disorders of Pregnancy: Recent Advances in Hypertension. Hypertension, Aug 2021.

Cerdiera S, Rana S, Karumanchi SA. Is Prolonging Gestation in Preeclampsia For Better or Worse in Preventing Cardiovascular Disease? Editorial, Hypertension. Hypertension. 2021 Nov;78(5):1395-1397. PMID: 34644174.

Karumanchi SA, Rana S, Robert Taylor. Book Chapter: Angiogenesis and Preeclampsia. Chesley’s hypertensive disorders in pregnancy, 7th Edition. Elsevier Inc. 2020, Chapter 6.

Garovic VD, Dechend R, Karumanchi SA, Baird SM, Easterling T, Magee LA, Rana S, Vermunt JV, August P, on behalf of the American Heart Association Council on Hypertension. Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy A Scientific Statement from the American Heart Foundation. IN PRESS, HTN, 2021.

Magee LA,Brown MA, Hall DR, Gupte S, Hennessy AS, Karumanchi SA, Kenny LC, McCarthy F, Myers J, Poon LC, Rana S, Saito S, Staff A, Tsigas E, Dadelszen PV, on behalf of the International Society for the Study of Hypertension in Pregnancy (ISSHP). THE HYPERTENSIVE DISORDERS OF PREGNANCY: THE 2020 ISSHP CLASSIFICATION, DIAGNOSIS & MANAGEMENT RECOMMENDATIONS FOR INTERNATIONAL PRACTICE, IN PRESS Preg HTN, 2021.

Docheva N, Arenas, Nieman K, Lopes-Perdigao J, Yeo JT, Rana S. Angiogenic Biomarkers for Risk Stratification in Women with Preeclampsia. IN PRESS, Clinical chemistry. 2021.

Hakim S, Bano I, Bhardwaj NA, Anis A, Rana S. Dermoid cyst of mons pubis: a case report. J Obstet Gynecol India 2000; 51: 121.

Saxena K, Haroon S, Rabbani T, Rana S.  Blood flow studies in evaluation of fetal wellbeing:  a study of normal and abnormal pregnancies.  J Obstet Gynecol lndia 2001; 51:64-72.

Rana S.  Practical strategies in Obstetrics & Gynecology (book review). Fertility Sterility 2000,74 (2): 425.

Rana S, Lindheimer MD, Karumanchi SA.  Angiogenic proteins as markers for predicting preeclampisa.  Expert Review of Obstet Gynecol 2007; 2(1): 61-65.

Wang A, Rana S, Karumanchi SA: Preeclampsia. Physiology. 2009; 24:147-58.

Tjoa M, Khankin E, Rana S, Karumanchi SA. Book Chapter: Angiogenic and anti-angiogenic factors. Placental Bed Disorders: Basic Science & its translation to obstetrics, Cambridge University Press. 2010, Section 7, Chapter 21.

Maski M, Rana S, Karumanchi SA. Book Chapter: Biomarkers in Obstetric Medicine. Biomarkers in Medicine, Drug Discovery, and Environmental Health, John Wiley and Sons. 2010, Section II, Chapter 13.

**Silasi M, Cohen B, Karumanchi SA, Rana, S: Abnormal Placentation, Angiogenic Factors, and the Pathogenesis of Preeclampsia. Obstetrics and Gynecology Clinics of North America. 2010; 37(2): 239-253.

Rana S, Karumanchi SA, Norwitz E. Book Chapter: Screening for hypertensive disorders of pregnancy. Hypertension in Pregnancy, Cambridge University Press. 2010, Chapter 4.

**Goel A and Rana S. Angiogenic Factors in Preeclampsia: Potential for Diagnosis and Treatment. Curr Opin Nephrol Hypertens. 2013; 22(6): 643-650.

Karumanchi SA, Rana S, Robert Taylor. Book Chapter: Angiogenesis and Preeclampsia. Chesley’s hypertensive disorders in pregnancy, Fourth Edition. Elsevier Inc. 2014, Chapter 6.

Rana S, Karumanchi SA. Book Chapter: Pathophysiology of preeclampsia. Fetal and Neonatal Physiology, Fifth edition. Elsevier Inc, 2015, Chapter 172.

Rana S, Karumanchi SA. Book Chapter: Angiogenic factors in Pre-eclampsia. World Clinics Obstetrics and Gynecology- Preeclampsia. 2016; 5(1): pp1-143.

Rana S, Sannon H. Angiogenic proteins: Can these biomarkers help to prevent maternal deaths related to preeclampsia? Editorial. Hypertension. 2017 Mar; 69(3):401-403.

Rana S. Does vasoactive peptide ELABELA reveal essential mechanisms for preeclampsia development?”. OB GYN management. October 29, 2017.

Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: Pathophysiology, Challenges, and Perspectives. Review. Circ Res. 2019 Mar 29;124(7):1094-1112. PMID: 30920918.

Rana S. Does planned early delivery makes sense in women with preterm preeclampsia”. OB GYN management. December, 2019.

Rana S, Karumanchi SA. Book Chapter: Pathophysiology of preeclampsia. Fetal and Neonatal Physiology, Fifth edition. Elsevier Inc, 2020, Chapter 172.

Rana S, Burke SD, Karumanchi SA. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. AJOG, 2020. PMID: 33096092.

**Sunitha Suresh, Rana S. The real world use of biomarkers in management of hypertension during pregnancy- adjunct to clinical care. Editorial, Hypertension. 2021 Feb;77(2):472-474. PMID: 33439732.

**Docheva, N, Rana S. Editorial. Treat it while you can: Use of Lasix in Management of Postpartum Hypertension. Editorial, Hypertension. 2021 May 5;77(5):1525-1527.PMID PMID: 33826400.

**Khosla K, Heimberger S, Nieman KM, Tung A, Shahul S, Staff AC, Rana S. Long-Term Cardiovascular Disease Risk in Women After Hypertensive Disorders of Pregnancy: Recent Advances in Hypertension. Hypertension, Aug 2021.

Cerdiera S, Rana S, Karumanchi SA. Is Prolonging Gestation in Preeclampsia For Better or Worse in Preventing Cardiovascular Disease? Editorial, Hypertension. Hypertension. 2021 Nov;78(5):1395-1397. PMID: 34644174.

Karumanchi SA, Rana S, Robert Taylor. Book Chapter: Angiogenesis and Preeclampsia. Chesley’s hypertensive disorders in pregnancy, 7th Edition. Elsevier Inc. 2020, Chapter 6.

Ahn Roy, Gonzalez G, Nadel T, TenBroeck S, Rana S. Literature Review Report: Promising Global Practices to Improve Maternal Mortality Outcomes in the United States. NORC at the University of Chicago. Report to the US Health Resources and Services Administration, Department of Health and Human Services. (2018). December 3, 2018. pp. 1-56.

IIRRH to Hold Conference on Reproductive Health from Nov 4, Webindia123. November 01, 2016.

Global health research in Haiti improves prenatal care back home, University of Chicago Medicine. July 17, 2018.

How Do Women Go from Having a Pregnancy Complication to Developing Cardiovascular Disease? JAMA. October 17, 2018. 

Preeclampsia in Pregnancy, WGNTV Healthy Living Chicago. February 18, 2019.

Pregnancy HTN Disorders Tied to Cardiomyopathy Risk. MedPage Today. March 08, 2019.

Durbin, Duckworth Help Introduce Maternal Care Act. Press Conference Interviewee. May 22, 2019.

Expertise in Pre-Eclampsia: Worldwide. Expertscape. May 22, 2019.

Understanding preeclampsia. University of Chicago Medicine. Facebook Live. May 22, 2019.

What pregnant women need to know about preeclampsia. Chicago Sun-Times. May 22, 2019. 

I Had a Sudden Seizure After Giving Birth: How Postpartum Preeclampsia Happened to Me. Parents Magazine. October 14, 2019.

Angiogenic Factors and Preeclampsia. Gold Obstetrics. Conference Presentation.

What you need to know about preeclampsia before – and after – pregnancy, University of Chicago Medicine. May 22, 2020.

Home Blood Pressure Monitoring to Improve Maternal Health. HHS Maternal Health Webinar Series. September 2020.

Addressing Racial Bias in Maternal Health Outcomes Through Data Disaggregation. More Inclusive Healthcare. October 2020.

Episode 7SN: The Fates Have their Own Birth Plan: Jules. Paulette Kamenecka. Podcast. February 2021.

Episode 11: Wrestling with Preeclampsia: Audrey. Paulette Kamenecka. Podcast. March 22, 2021.

Racism’s toll on Black women includes staggering maternal death rates. Chicago Tribune. May 3, 2021.

Panel Discussion: APEC Internal Inaugural Meeting. APEC. May 20, 2021.

Preeclampsia Education of the Nation, (India); PEN (I). The Society of Maternal Fetal Medicine (India) and The International Society for the Study of Hypertension in Pregnancy. Launched July 20, 2021.

Health Care Innovators: Fixing America’s Maternal Health Crisis. Politico. May 25, 2021.